Merck
CN
  • Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines.

Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines.

Bioorganic & medicinal chemistry letters (2005-09-06)
Zhi-Feng Xie, Kyu-Yun Chai, Hu-Ri Piao, Kyung-Chell Kwak, Zhe-Shan Quan
ABSTRACT

A series of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline derivatives was synthesized using 6-hydroxy-3,4-dihydro-1H-quinolin-2-one as a starting material. Their anticonvulsant activities were evaluated by the maximal electroshock test (MES test) and the subcutaneous (s.c.) pentylenetetrazol test (scMet test), and their neurotoxicity was evaluated by the rotarod neurotoxicity test (Tox). MES and scMet tests show that 7-(4-fluorobenzyloxy)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline 4l was found to be the most potent with ED50 value of 11.8 and 6.7 mg kg(-1) and protective index (PI = TD50/ED50) value of 4.6 and 8.1, respectively.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carbamazepine, meets USP testing specifications
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
Sigma-Aldrich
2-Propylpentanoic acid